Paul J. Hastings, Director at Pacira BioSciences, Inc. (PCRX), sold 533 shares at $56.95 ($30K) on 2022-07-11, disclosed to the SEC on 2022-07-13.
Scheduled sale ($30k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NKTX | SELL | 2025-06-20 | $3K | — | Filing → |
| NKTX | SELL | 2025-01-17 | $38K | — | Filing → |
| NKTX | SELL | 2024-06-20 | $10K | — | Filing → |